StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) stock

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 9/30
$1.99−0.02 (-1.00%)

Close on Nov 12, 2026Market cap $73.19MP/E –Yield –

Fortress Biotech statistics

81 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Nov 13, 2026 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$73.19M
$280.48M
Enterprise Value
-$46.84M
$148.62M
PS Ratio
1.07
3.60
PB Ratio
0.45
2.05
P/TBV Ratio
0.53
2.29
P/OCF Ratio
0.58
12.93

Enterprise valuationIndustry

EV / Sales
-0.68
2.60

Share statisticsIndustry

Shares Change (YoY)
20.4%
10.9%
Shares Change (QoQ)
0.37%
0.48%
Float
25M
49M
Shares Held by Insiders
31.6%
12.1%
Shares Held by Institutions
15.9%
56.4%

Short sellingIndustry

Short Interest
5M
–
Short Interest Change
1.95%
-0.76%
Days to Cover
23.59
5.13

Stock price statisticsIndustry

52-Week High
$4.53
–
52-Week Low
$1.79
–
20-Day Moving Average
$1.93
–
50-Day Moving Average
$2.15
–
200-Day Moving Average
$2.72
–
Average True Range (14)
$0.10
–
Price Change (1 Week)
8.15%
1.51%
Price Change (1 Month)
4.74%
-2.37%
Price Change (3 Months)
-32.1%
-21.1%
Price Change (6 Months)
-13.5%
-22.8%
Price Change (YTD)
-45.6%
-22.6%
Price Change (1 Year)
-25.7%
-21.0%
Price Change (3 Years)
48.5%
-24.8%
Price Change (5 Years)
-96.2%
-76.9%
Price Change (10 Years)
-95.1%
-63.2%
Average Volume (10 Days)
220,648
–
Average Volume (20 Days)
208,983
–
Average Volume (90 Days)
425,677
–
Relative Volume
0.70
0.80
Relative Strength Index (14)
48.9
44.7
Volatility (1 Year)
63.9%
80.2%
Beta (5 Years)
1.38
1.07

MarginsIndustry

Gross Margin
65.6%
53.0%
Operating Margin
-42.9%
-38.5%
Pretax Margin
213.0%
-11.8%
Profit Margin
163.3%
-31.7%
EBITDA Margin
-42.9%
-27.7%

Returns on capitalIndustry

Return on Equity (ROE)
107.5%
-51.3%
Return on Assets (ROA)
46.9%
-40.7%
Return on Invested Capital (ROIC)
-261.5%
-32.9%
Return on Capital Employed (ROCE)
-11.5%
-38.1%

Financial positionIndustry

Current Ratio
3.96
3.31
Quick Ratio
3.75
2.41
Debt / Equity
0.21
0.50
Interest Coverage
-3.05
-6.35

GrowthIndustry

Revenue Growth (YoY)
15.5%
7.26%
Revenue Growth (3Y CAGR)
-5.83%
2.25%
Revenue Growth (5Y CAGR)
6.77%
6.41%

EfficiencyIndustry

Asset Turnover
0.29
0.40
Inventory Turnover
2.24
2.73
Revenue Per Employee
$877.77K
$429.38K
Profits Per Employee
$1.43M
-$683.67K
Employee Count
78
75
WACC
12.6%
10.0%

Income statement (TTM)Industry

Revenue
$68.47M
$66.69M
Gross Profit
$44.91M
$116.10M
Operating Income
-$29.35M
-$20.99M
Pretax Income
$145.86M
-$13.23M
Net Income
$111.82M
-$21.61M
EBITDA
-$29.35M
-$16.85M

Balance sheetIndustry

Total Debt
$34.60M
$116.91M
Net Cash (Debt)
$161.97M
$16.98M
Net Cash Per Share
$4.40
$0.72
Equity (Book Value)
$164.14M
$52.68M
Book Value Per Share
$4.46
$1.50
Tangible Book Value
$138.63M
$26.74M
Working Capital
$183.49M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
$125.92M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
152.8%
-21.0%

Taxes and interestIndustry

Interest Expense
$9.63M
$2.97M
Income Tax
$4.66M
$74.00K
Effective Tax Rate
3.20%
20.9%

Scores and fair valueIndustry

Altman Z-Score
-1.76
0.26
Piotroski F-Score
6
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodFBIOS&P 500DifferenceFBIO per yearS&P 500 per year
1 month-5.7%-2.7%−3.0 pts
3 months-27.6%-1.7%−25.9 pts
Year to date-45.6%+11.9%−57.5 pts
1 year-24.0%+12.0%−36.0 pts
3 years+51.9%+78.2%−26.3 pts+15.0%+21.2%
5 years-96.2%+73.2%−169.4 pts-47.9%+11.6%
10 years-95.1%+309.6%−404.8 pts-26.0%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M FBIO shares were sold short on Oct 30, 2026, up 2.0% from the previous report. At recent volumes it would take 23.6 days to buy them back. Over the last 20 sessions, 50.2% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20264,611,017+2.0%195,47823.6
Oct 15, 20264,522,696-7.7%281,03316.1
Sep 30, 20264,898,052-4.1%266,43018.4
Sep 15, 20265,107,594-6.2%269,21919.0
Aug 31, 20265,443,900-2.4%454,93012.0
Aug 14, 20265,575,779-3.6%973,8195.7
Jul 31, 20265,784,483+7.5%481,09712.0
Jul 15, 20265,380,621+1.4%647,8198.3
Jun 30, 20265,305,659+3.2%627,0608.5
Jun 15, 20265,143,035+1.0%466,73011.0
May 29, 20265,090,428+4.3%450,02711.3
May 15, 20264,882,556+5.0%336,27414.5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?